Lung Cancer Foundation of America

Who’s a Veteran you’re looking out for this Lung Cancer Awareness Month? Today, LCFA took our lung cancer screening message across the country through a satellite media tour from New York City. We were joined by veteran and lung cancer advocate Gerry Spencer and Dr. Martin Edelman, a retired Navy Medical Corps captain and chair of LCFA’s Scientific Advisory Board. Here’s what we want every Veteran to know. 👊 1. If you’re eligible, get screened, even if you "feel fine." Low-dose CT scans find the cancer before symptoms appear, when it’s most treatable. Dr. Edelman shares that lung cancer screening is underutilized. 2. Know your exposures. Burn pits, Agent Orange, and asbestos are a few types. Desert Storm Veteran and LCFA advocate Michelle Alarid remembers “the burning oil that I breathed in.” Every Veteran enrolled in VA health care can get a free toxic exposure screening – share a 5–10 minute conversation with your provider about what you may have been exposed to. 3. If you’re diagnosed, know your biomarkers. Biomarker testing can match lung cancer to the treatment most likely to work. For Michelle, it led to a targeted therapy that has let her keep living an active life. 4. The VA can be a partner in making screening work better. At the MINNEAPOLIS VA MEDICAL CENTER, a new coordination program increased rates of expert follow-up for high-risk lung nodules from 45% to 100% and cut wait times for results in half. The VA’s National Center for Lung Cancer Screening says that every VA site should bring community-care screening into its program. Get screened. Then tell another Veteran to do the same. Learn more and check your eligibility: lcfamerica.org/get-involved/…

Biomarker testing can find changes like EGFR, KRAS, and PD-L1, and many point to treatments that didn’t exist 10 years ago. That’s The Science of More Options. Follow along this #LungCancerAwarenessMonth: bit.ly/4feZ3hn

November is #LungCancerAwarenessMonth. If you have lungs, you can get lung cancer. Join us all month: wear a white ribbon, share what you learn, and get LCAM updates: bit.ly/4feZ3hn #LungCancer #BiomarkerTesting #LivingWithLungCancer #LungCancerAwarenessMonth #EGFR #KRAS #NewlyDiagnosed #LCAM2026

Today kicks off #LungCancerAwarenessMonth. 🤍 More than 1 in 4 people with lung cancer now live 5+ years, up from about 1 in 8 in the 1970s. That's what research does. See what's changed and help fund what's next 👇 bit.ly/4feZ3hn #LCAM2026 #ResearchMatters

Burn pits. Agent Orange. Asbestos. Jet fuel. Your service had risks—screening is how you fight back. Eligible Veterans can get a quick, no-cost lung cancer screening through VA health care. Check if you qualify, then fist-bump a buddy to do the same. 👊 bit.ly/3Wd8XvS #BreathOfHonor #Veterans #LivingWithLungCancer

🇺🇸 An estimated 900,000 Veterans are eligible for lung cancer screening. Screening only helps if people know it’s there. If you served, or you love someone who did, share this. It could lead to the screening they’ve earned. 🎗️ Check eligibility: bit.ly/4e9SJd3

My friend Lori would have been 68 yesterday. In 2001, she was diagnosed with stage 4 lung cancer. Her doctor told her that her cancer was inoperable. Being a nurse, and knowledgeable about patient care, she didn’t stop at a second opinion – she got a third, then a fourth… She saw that lung cancer was the leading cause of cancer death, and she also saw that despite that, research for lung cancer was underfunded. Using her southern charm along with her knowledge from being a nurse and a patient, she went head to head with politicians and public leaders to advocate for lung cancer to get the attention and funding it deserved. So in 2007, we co-founded Lung Cancer Foundation of America together with David Sturges, another patient advocate. Our mission today is the same: to improve survival for people with lung cancer by funding transformative science. I hope she can see the researchers we've funded and the cumulative impact of the chances we took on those bright, bold, young minds. Lori also gave her time and attention to anyone who needed it, from patients to caregivers and gave them hope. When Lori was diagnosed, she hoped to see her daughters graduate high school. She saw them graduate college and danced at her youngest daughter’s wedding. She passed away too soon in 2013. We’re still funding lung cancer research - for Lori, for everyone like her, for everyone who has and loves the “Lori” in their life. We miss you. - Kim Norris, President of Lung Cancer Foundation of America

Veteran and lung cancer survivor Michelle has been on a targeted therapy since 2018. LCFA-funded researcher Dr. Jaime Schneider is studying why treatments like hers can stop working. #LCAM2026 Learn more: bit.ly/4knclOs #LungCancer

For Stephanie Williams, more options mean book fairs and Halloween parties with her daughter. Meanwhile, researchers like Dr. Jaime L. Schneider are finding out why some lung cancers stop responding to treatment. Learn more about the science of more optoins as we head into lung cancer awareness month: bit.ly/44vOl1T #LungCancerAwarenessMonth #LungCancerResearch #ALKPositive #LivingWithLungCancer #LCAM2026

November’s almost here. 🤍 This #LungCancerAwarenessMonth, we stand with Veterans, who face higher risk from service exposures. 🎗️ Wear white (+ red/blue for Vets) 🩻 See if you qualify for free screening 📣 Post your ribbon w/ #WhiteRibbonProject. 🇺🇸🤍 #BreathOfHonor lcfamerica.org/get-involved/…

What is PD-L1, and why does it matter for lung cancer treatment? Survivor Jane Perlmutter and host James Hiter explain how it guides immunotherapy and what to ask your care team. 🎧: bit.ly/3UBYwkT #LungCancer

“It’s always worthwhile to ask.” On #AskMeAnything, James Hiter and Stephanie Williams talk patient to patient about IV vs. subcutaneous lung cancer treatment and how to bring it up with your doctor. bit.ly/489LwG9

A 90–120 minute infusion can become a 3–6 minute injection. Dr. Coral Olazagasti and patient host Jeanne Szurek talk switching from IV to SubQ: eligibility, side effects, and insurance. 🎧:bit.ly/4dKovwX #LungCancer

Diagnosed with SCLC at 28 in 2006. Still here, still advocating. Montessa Lee on why there’s new hope in small cell lung cancer. Listen to our latest podcast 🎧: bit.ly/3WlxWwP

Jane Perlmutter’s PD-L1 score came back at 20%, but immunotherapy worked for her anyway. Her story is on our Ask Me Anything podcast. 🎧 Make it a double feature: 1️⃣ Start with Hope With Answers. Dr. Julie Brahmer and Colette Smith explain what a PD-L1 score is and what it means for lung cancer treatment. 2️⃣ Then listen to Ask Me Anything. Advocates Jane Perlmutter and James Hiter talk about the experience of immunotherapy based on PD-L1 scoring. Watch on YouTube or listen wherever you get podcasts. #LungCancer #PDL1 #BiomarkerTesting #Immunotherapy #LCFA

Immunotherapies, ADCs, combination therapies, SCLC subtypes: small cell lung cancer research is moving fast. Wendy Brooks and Dr. Ashish Saxena break it down on #HopeWithAnswers. bit.ly/3UDh5VS #SCLC #LCSM